2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease --- Part I.

Autor: Chao TH; Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan.; Division of Cardiology, Department of Internal Medicine, Chung-Shan Medical University Hospital; School of Medicine, Chung Shan Medical University, Taichung., Lin TH; Division of Cardiology, Department of Internal Medicine Kaohsiung Medical University Hospital.; Faculty of Medicine and Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University., Cheng CI; Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung; School of Medicine, College of Medicine, Chang Gung University, Taoyuan., Wu YW; Division of Cardiology, Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City.; School of Medicine, National Yang Ming Chiao Tung University, Taipei.; Graduate Institute of Medicine, Yuan Ze University, Taoyuan., Ueng KC; Division of Cardiology, Department of Internal Medicine, Chung-Shan Medical University Hospital; School of Medicine, Chung Shan Medical University, Taichung., Wu YJ; Department of Medicine and Institute of Biomedical Sciences, MacKay Medical College, New Taipei City.; Cardiovascular Center, Department of Internal Medicine, MacKay Memorial Hospital, Taipei., Lin WW; Cardiovascular Center, Taichung Veterans General Hospital, Taichung., Leu HB; School of Medicine, National Yang Ming Chiao Tung University, Taipei.; Cardiovascular Research Center, National Yang Ming Chiao Tung University.; Healthcare and Management Center.; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital., Cheng HM; Ph.D. Program of Interdisciplinary Medicine (PIM), National Yang Ming Chiao Tung University College of Medicine; Division of Faculty Development; Center for Evidence-based Medicine, Taipei Veterans General Hospital; Institute of Public Health; Institute of Health and Welfare Policy, National Yang Ming Chiao Tung University College of Medicine., Huang CC; School of Medicine, National Yang Ming Chiao Tung University, Taipei.; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital.; Institute of Pharmacology, National Yang Ming Chiao Tung University, Taipei., Wu CC; Center of Quality Management, National Taiwan University Hospital Hsinchu Branch, Hsinchu; College of Medicine, National Taiwan University, Taipei; Institute of Biomedical Engineering, National Tsing-Hua University, Hsinchu; Institute of Cellular and System Medicine, National Health Research Institutes, Zhunan., Lin CF; Department of Medicine, MacKay Medical College, New Taipei City; Department of Cardiology, MacKay Memorial Hospital, Taipei., Chang WT; School of Medicine and Doctoral Program of Clinical and Experimental Medicine, College of Medicine and Center of Excellence for Metabolic Associated Fatty Liver Disease, National Sun Yat-sen University, Kaohsiung; Division of Cardiology, Department of Internal Medicine, Chi Mei Medical Center, Tainan., Pan WH; Institute of Biomedical Sciences, Academia Sinica, Taipei; Institute of Population Health Sciences, National Health Research Institutes, Miaoli; and Institute of Biochemistry and Biotechnology, National Taiwan University., Chen PR; Department of Dietetics, National Taiwan University Hospital, Taipei., Ting KH; Division of Cardiology, Department of Internal Medicine, Yunlin Christian Hospital, Yunlin., Su CH; Division of Cardiology, Department of Internal Medicine, Chung-Shan Medical University Hospital; School of Medicine, Chung Shan Medical University, Taichung., Chu CS; Division of Cardiology, Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung., Chien KL; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University; Department of Internal Medicine, National Taiwan University Hospital and College of Medicine; Population Health Research Center, National Taiwan University, Taipei., Yen HW; Division of Cardiology, Department of Internal Medicine Kaohsiung Medical University Hospital., Wang YC; Division of Cardiology, Asia University Hospital; Department of Medical Laboratory Science and Biotechnology, Asia University; Division of Cardiology, China Medical University College of Medicine and Hospital, Taichung., Su TC; Cardiovascular Center, Department of Internal Medicine, National Taiwan University Hospital.; Department of Environmental and Occupational Medicine, National Taiwan University College of Medicine., Liu PY; Division of Cardiology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center., Chang HY; Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan., Chen PW; Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan., Juang JJ; Heart Failure Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University College of Medicine, and National Taiwan University Hospital., Lu YW; Cardiovascular Center, Taichung Veterans General Hospital, Taichung.; Cardiovascular Research Center, National Yang Ming Chiao Tung University.; Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei., Lin PL; Division of Cardiology, Department of Internal Medicine, Hsinchu MacKay Memorial Hospital, Hsinchu., Wang CP; Division of Cardiology, E-Da Hospital; School of Medicine for International Students, College of Medicine, I-Shou University, Kaohsiung., Ko YS; Cardiovascular Division, Chang Gung Memorial Hospital; College of Medicine, Chang Gung University, Taoyuan., Chiang CE; General Clinical Research Center and Division of Cardiology, Taipei Veterans General Hospital and National Yang Ming Chiao Tung University., Hou CJ; Cardiovascular Center, Department of Internal Medicine, MacKay Memorial Hospital, Taipei., Wang TD; Cardiovascular Center and Divisions of Hospital Medicine and Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine., Lin YH; Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei., Huang PH; Cardiovascular Research Center, National Yang Ming Chiao Tung University.; Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital., Chen WJ; Department of Internal Medicine, Min-Sheng General Hospital, Taoyuan; Department of Internal Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Jazyk: angličtina
Zdroj: Acta Cardiologica Sinica [Acta Cardiol Sin] 2024 Sep; Vol. 40 (5), pp. 479-543.
DOI: 10.6515/ACS.202409_40(5).20240724A
Abstrakt: Atherosclerotic cardiovascular disease (ASCVD) is one of the leading causes of death worldwide and in Taiwan. It is highly prevalent and has a tremendous impact on global health. Therefore, the Taiwan Society of Cardiology developed these best-evidence preventive guidelines for decision-making in clinical practice involving aspects of primordial prevention including national policies, promotion of health education, primary prevention of clinical risk factors, and management and control of clinical risk factors. These guidelines cover the full spectrum of ASCVD, including chronic coronary syndrome, acute coronary syndrome, cerebrovascular disease, peripheral artery disease, and aortic aneurysm. In order to enhance medical education and health promotion not only for physicians but also for the general public, we propose a slogan (2H2L) for the primary prevention of ASCVD on the basis of the essential role of healthy dietary pattern and lifestyles: " Healthy Diet and Healthy Lifestyles to Help Your Life and Save Your Lives ". We also propose an acronym of the modifiable risk factors/enhancers and relevant strategies to facilitate memory: " ABC 2 D 2 EFG-I'M 2 ACE" : Adiposity, Blood pressure, Cholesterol and Cigarette smoking, Diabetes mellitus and Dietary pattern, Exercise, Frailty, Gout/hyperuricemia, Inflammation/infection, Metabolic syndrome and Metabolic dysfunction-associated fatty liver disease, Atmosphere (environment), Chronic kidney disease, and Easy life (sleep well and no stress). Some imaging studies can be risk enhancers. Some risk factors/clinical conditions are deemed to be preventable, and healthy dietary pattern, physical activity, and body weight control remain the cornerstone of the preventive strategy.
Competing Interests: Ting-Hsing Chao has been on the speaker bureau for Astrazeneca, Bayer, Eli Lilly, Boehringer Ingelheim, Daiichi-Sankyo, MSD, Novartis, Pfizer, Sanofi, Tanabe, and TSH biopharm. All other authors report no potential conflicts of interest in relation to these guidelines.
Databáze: MEDLINE
Externí odkaz: